Glucodigifucoside

CAS : 2446-63-1

Ref. 3D-CAA44663

Informations sur le produit

• Nom: Glucodigifucoside
• Synonymes: 5β-Card-20(22)-enolide, 3β-[(6-deoxy-4-O-β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β)-3-[(6-Deoxy-4-O-β-D-glucopyranosyl-L-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, Card-20(22)-enolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-L-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β)-

Description

Glucodigifucoside is a purpurea that has been shown to have cytotoxic effects against cancer cells. It has been found to be a potent cytotoxic agent, which inhibits the growth of tumour cells in vitro and in vivo. The structure of glucodigifucoside was determined by NMR spectroscopy, and it was found to bear a close resemblance to lanatosides A and B, cardenolides, and cardiac glycosides. Glucodigifucoside also contains six hydroxyl groups, which can be acetylated with acetic anhydride.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 682.8 g/mol
• Formule: C₃₅H₅₄O₁₃
• Degré de pureté: Min. 95%